Tai Sandi See, Chief Development Officer at Lexeo Therapeutics, Inc. (LXEO), sold 3,888 shares at $9.56 ($35K) on 2025-10-17, disclosed to the SEC on 2025-10-17.
Open-market sale of $35k LXEO by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.94 | 3,844 | $34K | 98.8% |
| 2 | $9.56 | 44 | $421 | 1.2% |
| Total | $8.95 avg | 3,888 | $35K | 100% |
| Filing → |
| LXEO | SELL | 2025-05-20 | $1K | — | Filing → |
| LXEO | SELL | 2025-02-21 | $7K | — | Filing → |